Skip to main content
Creotech Instruments S.A. logo

Creotech Instruments S.A. — Investor Relations & Filings

Ticker · CRI ISIN · PLCRTCH00017 LEI · 259400UEC5P401GDDB94 WAR Manufacturing
Open in API
Filings indexed 483 across all filing types
Latest filing 2023-04-01 Board/Management Inform…
Country PL Poland
Listing WAR CRI

About Creotech Instruments S.A.

https://creotech.pl/

Creotech Instruments S.A. is a manufacturer of satellite systems, platforms, and components. The company specializes in developing and producing advanced electronics, including control systems for quantum computing and measurement systems for scientific research. It offers comprehensive, high-reliability contract electronic assembly services for the aerospace, automotive, and medical sectors, holding a unique certification from the European Space Agency (ESA) for these operations. The company's portfolio also includes geospatial data processing services and operational support using drones.

Recent filings

Filing Released Lang Actions
Powołanie Wiceprezesa Zarządu ds. Finansowych - Content (PL)
Board/Management Information Classification · 1% confidence The document text is an official announcement from the Management Board ('Zarząd') of Creotech Instruments S.A. regarding the appointment of Mr. Paweł Górnicki as the Vice President of the Management Board for Financial Affairs, effective April 1, 2023. It details his qualifications, certifications (ACCA, Lean Six Sigma), and extensive professional experience, including previous CFO roles. This content directly relates to changes in senior management personnel. Therefore, the appropriate classification is Board/Management Information (MANG). The document is short and appears to be the primary announcement, not a mere link to a report.
2023-04-01 Polish
Podpisanie umowy na realizację kolejnych faz misji kosmicznej Comet Interceptor - Content (PL)
Regulatory Filings Classification · 1% confidence The document is a formal announcement by the management board ('Zarząd spółki') of Creotech Instruments S.A. regarding the signing of a contract with the European Space Agency (ESA) for the development and production of a key component for the Comet Interceptor space mission. This concerns a significant business agreement, project scope, and contract value (€1,798,519 EUR) with a defined completion date. This type of announcement, detailing a major business transaction or contract signing that impacts the company's operations or future, best fits the 'Capital/Financing Update' (CAP) if it were about fundraising, or more generally, a significant corporate event. Since it is a major contract signing that is not explicitly covered by other categories like M&A (TAR) or Director's Dealing (DIRS), and it represents a significant business development, it is most closely related to major corporate activities. Given the options, and recognizing this as a significant business contract announcement, it does not fit perfectly into the defined categories like ER, IR, or 10-K. However, it is a specific corporate action announcement. If we strictly adhere to the definitions, it is a significant business development. It is not a financing activity (CAP), nor a management change (MANG). It is a report on a major business contract. In many regulatory contexts, major contract awards are often grouped under general regulatory filings or significant event disclosures. Given the available codes, and since it details a major business undertaking, it is closest to a general regulatory filing (RNS) or potentially a Capital/Financing Update (CAP) if the contract is viewed as securing future revenue/work, but RNS is the safest fallback for specific, non-standard corporate news. Given the nature of the announcement (signing a major contract for a space mission), it is a significant corporate event disclosure. I will classify it as RNS as it is a specific, material announcement that doesn't fit the other specific financial/governance codes.
2023-03-20 Polish
Informacja o zmianie adresu siedziby - Content (PL)
Regulatory Filings Classification · 1% confidence The document text is very short (317 characters) and announces a change in the registered office address ('zmiana adresu siedziby Emitenta') for Creotech Instruments S.A., effective March 1, 2023. This type of administrative change, which affects the company's official registration details but is not a core financial report (like 10-K, IR, or ER), typically falls under general regulatory announcements or miscellaneous corporate actions. Since there is no specific category for 'Change of Registered Address,' and it is not a Director's Dealing (DIRS), Management Change (MANG), or Capital Change (CAP), the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements that do not fit elsewhere.
2023-03-02 Polish
Rezygnacja Wiceprezesa Zarządu ds. Finansowych - Content (PL)
Board/Management Information Classification · 1% confidence The document text is very short (474 characters) and announces a specific change in senior management: the resignation of the Vice President of Finance (Wiceprezesa Zarządu ds. Finansowych), Mr. Maciej Kielka, effective March 31, 2023. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in senior management.
2023-02-28 Polish
Informacja o zakończeniu negocjacji z Europejską Agencją Kosmiczną dotyczących projektu Quantum Key Distribution High Rate Detector Predevelopment - Content (PL)
Regulatory Filings Classification · 1% confidence The document is a formal announcement from the Management Board ('Zarząd') of Creotech Instruments S.A. written in Polish. It details the successful conclusion of negotiations with the European Space Agency (ESA) regarding a contract for a project ('QUANTUM KEY DISTRIBUTION HIGH RATE DETECTOR PREDEVELOPMENT'). The text specifies the contract value (EUR 799,128.07), the duration (33 months), and the nature of the work (quantum key distribution detector). Crucially, it states that the formal signing of the agreement is planned for March 2023 and that the Management Board will inform about the signing in a separate current report ('w formie odrębnego raportu bieżącego'). Since this document announces a significant business development (a new contract/financing activity) but is not the final contract document itself, nor is it a standard financial report (10-K, IR, ER), it best fits the category for updates on financing activities or significant business deals. Given the options, 'Capital/Financing Update' (CAP) is the most appropriate fit as it relates to securing a major contract/funding source, although 'Regulatory Filings' (RNS) is a possibility if the specific nature of the contract announcement doesn't fit other categories well. However, securing a major contract worth nearly 800k EUR is a significant capital/business development event. Since the document is short and announces a future action (signing the contract), it leans towards a specific business update rather than a general regulatory filing. I will classify it as CAP because it concerns securing a major contract/funding, which impacts capital structure/future revenue.
2023-02-14 Polish
Podpisanie umowy na projekt "New imaging and control solutions for quantum and metrology" - Content (PL)
Regulatory Filings Classification · 1% confidence The document is a short announcement (1292 characters) from the Management Board ('Zarząd') of Creotech Instruments S.A. It references a previous current report and details the signing of a contract with the National Centre for Research and Development (NCBR) for a research project ('New imaging and control solutions for quantum and metrology') under the QuantERA program. It describes the project's goal (developing a super-sensitive camera for quantum systems), partners (Max Planck Institute, Institute of Physics in Zagreb), timeline (until April 2025), budget (2.4 million PLN), and future commercialization plans. This content describes a significant business development, specifically related to R&D funding and contract signing, which falls under financing activities or major operational updates. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a dividend notice (DIV), and it details a major contract/project funding, it best fits the 'Capital/Financing Update' category (CAP) or potentially a general 'Regulatory Filing' (RNS) if CAP is too specific. Given the focus on securing funding/a major contract for a project, CAP is the most appropriate specific classification, as it relates to capital structure/financing activities for future growth/projects. It is not a simple announcement of a report publication (RPA).
2023-02-08 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.